Stock Information. NASDAQ Capital Market:MBRX. $4.60. Apr 24, 2024 9:16 AM ET ... Investor Relations. JTC Team, LLC. Jenene Thomas T: 833-475-8247 mbrx@jtcir.com ...
16 hours ago · Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity.
Live webcast on Thursday, April 4th at 4:10 PM ET HOUSTON, March 28, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a ...
Get the latest Moleculin Biotech, Inc. (MBRX) stock news and headlines to help you in your trading and investing decisions.
Missing: relations | Show results with:relations
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more. Before you Invest, Investor.gov. Get ...
Missing: relations | Show results with:relations
Moleculin Biotech, Inc. Common Stock (MBRX) SEC Filings - Nasdaq
www.nasdaq.com › ... › Stocks › MBRX
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Find the latest Moleculin Biotech, Inc. (MBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
People also ask
Is MBRX stock a buy?
Get the latest updates on Moleculin Biotech, Inc. Common Stock (MBRX) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Nov 13, 2023 · Participated in the Virtual Investor ... Moleculin Biotech, Inc., (Nasdaq: MBRX) ... Products. For Marketers · For Public Relations · For IR & ...
Address: 5300 Memorial Drive, Suite 950, Houston, TX 77007 ; Main Phone Number, 713-300-5160 ; Fax Number, Not Available ; Investor Contact Jenene Thomas, JTC Team ...